Vitrolife AB (publ) (LON:0YAY)
158.46
+2.06 (1.32%)
At close: May 9, 2025
Vitrolife AB Revenue
Vitrolife AB had revenue of 842.00M SEK in the quarter ending March 31, 2025, with 0.12% growth. This brings the company's revenue in the last twelve months to 3.61B, up 3.17% year-over-year. In the year 2024, Vitrolife AB had annual revenue of 3.61B with 2.76% growth.
Revenue (ttm)
3.61B SEK
Revenue Growth
+3.17%
P/S Ratio
5.92
Revenue / Employee
3.09M SEK
Employees
1,169
Market Cap
1.65B GBP
Revenue Chart
* This company reports financials in SEK.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.61B | 97.00M | 2.76% |
Dec 31, 2023 | 3.51B | 278.00M | 8.60% |
Dec 31, 2022 | 3.23B | 1.55B | 92.39% |
Dec 31, 2021 | 1.68B | 435.43M | 34.96% |
Dec 31, 2020 | 1.25B | -234.56M | -15.85% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 42.56B |
GSK plc | 31.53B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Genus | 671.60M |